Eisai Inc. has announced the appointments of Yuji Matsue as chairman and chief executive officer and Shaji Procida as president and chief operating officer, effective April 1, 2014. Mr. Matsue and Ms. Procida succeed current President and CEO Lonnel Coats, who will be retiring from Eisai in June 2014 after 18 years.
The South Carolina Court of Common Pleas, Fifth Judicial Circuit has issued a ruling that will...
FMC Corporation today announced plans to separate into two independent public companies, "New...
Alexion Pharmaceuticals raised its 2014 guidance on Monday, saying the national health agency of France will reimburse it for past sales of its drug Soliris.
The Water Interest Group addresses topics in pharmaceutical water quality, analytical and microbiological control, rouging and biofilm concerns, continued water monitoring and compendial issues. The interest group is providing for an on-going forum for the exchange and dissemination of information and ideas for the purpose of education, innovation, and compliance related to purified water science.
Harvard Bioscience, a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, has named Ronald Aplin to Vice President Global Operations and Quality, effective immediately.
The Supreme Court has rejected an appeal from a Pennsylvania school district that wants to prevent students from wearing "I (heart) Boobies!" bracelets to promote breast cancer awareness among young people.
Promethera Biosciences and EMD Millipore to Deliver a Pre-Clinical Liver Pharmaco-Toxicological Testing AssayMarch 10, 2014 11:11 am | Comments
Promethera Biosciences has announced a collaboration with EMD Millipore to develop an improved ready-to-use microfluidic perfusion liver assay. This new product is designed to perform more robust studies in pre-clinical toxicity and drug metabolism.
Lundbecktoday announced that the FDA has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine
Amneal Pharmaceuticals and Intrexon Corporation today announced the formation of an Exclusive Channel Collaboration (ECC) to develop an improved production process for a complex active pharmaceutical ingredient (API).
Progenitor Cell Therapy has expanded both its Allendale, NJ and Mountain View, CA current Good Manufacturing Practice facilities to significantly increase its engineering and process development laboratories, and controlled environment space available for client needs.
Attorney General Eric Holder is calling the increase in heroin-related deaths an "urgent public health crisis" and says first responders should carry with them drugs to reverse the effects of an overdose.
With just three weeks left to sign up under President Barack Obama's health care law, a major survey tracking the rollout finds that the uninsured rate keeps going down. The Gallup-Healthways Well-Being Index, released Monday, found that 15.9 percent of U.S. adults are uninsured thus far in 2014, down from 17.1 percent for the last three months.
The stigma of leprosy endures in India, even though the country has made great strides against the disease, which is neither highly contagious nor fatal. Now the number of new annual cases has risen slightly after years of steady decline, and medical experts say the enormous fear surrounding leprosy is hindering efforts to finally eliminate it.
Finesse Solutions, a manufacturer of measurement and control solutions for life sciences process applications, has announced a partnership agreement with Spectra Automation, a control system integrator in Massachusetts.
As drug development continues to increase complexity, so do the primary packaging solutions that are being employed. Primary containers are no longer to considered as inert components whose sole function is to contain a drug product, but rather as an integral part of a drug delivery system.
The bill backed by Republicans decriminalizes cannabidiol, also known as CBD oil, if a patient has a doctor's prescription or is participating in a clinical trial for treating severe forms of epilepsy.
Acorn Applications, a developer of cloud-based analytic clinical research solutions, announced today that Clintrax Global, a clinical trial contract negotiation company, has selected TrialCTA as its new global contract management software solution.